MetaCap

Tessera Defense and Homeland Security Insider Trades

NYSE: HLSQHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.285-0.0065 (-2.23%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
4 · $8.25M
Shares bought / sold
0 / 1.65M
Net activity
Net selling $8.3 million

Tessera Defense and Homeland Security insider activity

Over the last 12 months, Tessera Defense and Homeland Security insiders reported 8 transactions on SEC Form 4: 0 open-market purchases and 4 sales. Insiders bought $0 and sold $8.3 million worth of stock, for net insider selling of $8.3 million. The largest seller was Yeganeh Reuven, with $8.3 million in reported sales.

The most recent filing shows Yeganeh Reuven (Director) reporting a transaction in 530,000 shares at $2.00 on Mar 17, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put HLSQ's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

HLSQ insider transactions

Tessera Defense and Homeland Security insider transactions
DateInsiderTypeSharesValueFiling
Mar 17, 2026Yeganeh ReuvenDirectorSale530,000$2.65MForm 4
Mar 17, 2026Yeganeh ReuvenDirectorConversion530,000$1.06MForm 4
Mar 16, 2026Yeganeh ReuvenDirectorSale450,000$2.25MForm 4
Mar 16, 2026Yeganeh ReuvenDirectorConversion450,000$900.00KForm 4
Mar 13, 2026Yeganeh ReuvenDirectorSale370,000$1.85MForm 4
Mar 13, 2026Yeganeh ReuvenDirectorConversion370,000$740.00KForm 4
Mar 12, 2026Yeganeh ReuvenDirectorSale300,000$1.50MForm 4
Mar 11, 2026Yeganeh ReuvenDirectorConversion300,000$600.00KForm 4
Apr 14, 2025Solomon Jonathan EitanChief Executive OfficerAward126,748—Form 4
Apr 14, 2025Bassan MeravChief Development OfficerAward79,597—Form 4
Apr 14, 2025Wolfson MarinaChief Financial OfficerAward68,545—Form 4
Apr 14, 2025Wolfson MarinaChief Financial OfficerAward68,545—Form 4
Apr 14, 2025Bassan MeravChief Development OfficerAward79,597—Form 4
Apr 14, 2025Solomon Jonathan EitanChief Executive OfficerAward126,748—Form 4
Feb 27, 2025Flynn James E & DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) & Deerfield Mgmt V, L.P. & Deerfield Mgmt HIF, L.P. & Deerfield Private Design Fund V, L.P. & Deerfield Healthcare Innovations Fund II, L.P.DirectorOption exercise353,249$328.73KForm 4
Feb 27, 2025Flynn James E & DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) & Deerfield Mgmt V, L.P. & Deerfield Mgmt HIF, L.P. & Deerfield Private Design Fund V, L.P. & Deerfield Healthcare Innovations Fund II, L.P.DirectorOption exercise353,249$328.73KForm 4
Sep 16, 2024Oron AssafChief Business OfficerAward25,804—Form 4
Sep 16, 2024Solomon Jonathan EitanChief Executive OfficerAward50,556—Form 4
Sep 16, 2024Bassan MeravChief Development OfficerAward31,749—Form 4
Jul 15, 2024Flynn James E & DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) & Deerfield Mgmt V, L.P. & Deerfield Mgmt HIF, L.P. & Deerfield Private Design Fund V, L.P. & Deerfield Healthcare Innovations Fund II, L.P.DirectorOption exercise5,883,000—Form 4
Jul 15, 2024Flynn James E & DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) & Deerfield Mgmt V, L.P. & Deerfield Mgmt HIF, L.P. & Deerfield Private Design Fund V, L.P. & Deerfield Healthcare Innovations Fund II, L.P.DirectorOption exercise5,883,000—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related